Abilify Maintena Information
Abilify Maintena is the first and only approved once-monthly injectable for both schizophrenia and maintenance treatment of bipolar I disorder in adults. Along with the first injection, patients should take oral aripiprazole or current oral antipsychotic for 14 consecutive days. It is not approved for the treatment of patients with dementia-related psychosis.
We are carrying Abilify Maintena intramuscular injection comes from Canada and United Kingdom and it is manufactured by Otsuka Pharmaceuticals. It is available in 300 mg and 400 mg strengths.
The content on this page has been supplied to canadianpharmacyking by an independent third party contracted to provide information for our website.
canadianpharmacyking relies on these third parties to create and maintain this information and cannot guarantee the medical efficacy, accuracy or reliability of the information that has been provided to us.
If you require any advice or information about the drugs on this page, a medical condition or treatment advice, you should always speak to a health professional.
Please note that not all products, including any referenced in this page, are shipped by our affiliated Canadian Pharmacy.
We affiliate with other dispensaries that ship product to our customers from the following jurisdictions: Canada, Singapore, New Zealand, Turkey, Mauritius, India, and United Kingdom.
The items in your order maybe shipped from any of the above jurisdictions.
The products are sourced from various countries as well as those listed above. Rest assured, we only affiliate with our authorized dispensaries that procure product through reliable sources.